Serum prolidase activity as an indicator of liver fibrosis in chronic hepatitis B infection

dc.contributor.authors	Kaleli, S; Karabay, O; Guclu, E; Karabay, M;
dc.date.accessioned	2020-02-27T08:26:26Z
dc.date.available	2020-02-27T08:26:26Z
dc.date.issued	2017
dc.identifier.citation	Kaleli, S; Karabay, O; Guclu, E; Karabay, M; (2017). Serum prolidase activity as an indicator of liver fibrosis in chronic hepatitis B infection. BIOMEDICAL RESEARCH-INDIA, 28, 7607-7604
dc.identifier.issn	0970-938X
dc.identifier.uri	https://hdl.handle.net/20.500.12619/65811
dc.description.abstract	Conclusions: SPA activity is considerably increased in CHB patients having liver damage. So, we think that SPA can be candidate as a non-invasive biomarker for liver fibrosis.
dc.language	English
dc.publisher	ALLIED ACAD
dc.subject	Research & Experimental Medicine
dc.title	Serum prolidase activity as an indicator of liver fibrosis in chronic hepatitis B infection
dc.type	Article
dc.identifier.volume	28
dc.identifier.startpage	7604
dc.identifier.endpage	7607
dc.contributor.department	Sakarya Üniversitesi/Tıp Fakültesi/Temel Tıp Bilimleri Bölümü
dc.contributor.saüauthor	Kaleli, Süleyman
dc.contributor.saüauthor	Karabay, Oğuz
dc.contributor.saüauthor	Güçlü, Ertuğrul
dc.contributor.saüauthor	Karabay, Meltem
dc.relation.journal	BIOMEDICAL RESEARCH-INDIA
dc.identifier.wos	WOS:000412656000049
dc.identifier.eissn	0976-1683
dc.contributor.author	Kaleli, Süleyman
dc.contributor.author	Karabay, Oğuz
dc.contributor.author	Güçlü, Ertuğrul
dc.contributor.author	Karabay, Meltem